# US 2013/0252840 A1 · Liquid tissue preparation from histopathologically processed biologically samples, tissues and cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0252840 A1
- Document ID: US20130252840A1
- Status: Published application
- Kind: A1
- Application number: 13/896,778
- Filed: 2013-05-17
- Published: 2013-09-26
- Earliest claimed: 2003-03-10
- Assignees: Expression Pathology, Inc.
- Applicants: Expression Pathology, Inc.
- Inventors: Marlene M. Darfler; David B. Krizman
- Web page: https://patentgrep.com/patent/US20130252840A1

## CPC

- G01N 1/4044: {by chemical techniques; Digestion; Chemical decomposition}
- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12Q 1/37: involving peptidase or proteinase
- G01N 1/44: Sample treatment involving radiation, e.g. heat
- G01N 1/30: Staining; Impregnating {; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The current invention provides a method for directly converting histopathologically processed biological samples, tissues, and cells into a multi-use biomolecule lysate. This method allows for simultaneous extraction, isolation, solublization, and storage of all biomolecules contained within the histopathologically processed biological sample, thereby forming a representative library of said sample. This multi-use biomolecule lysate is dilutable, soluble, capable of being fractionated, and used in any number of subsequent experiments.

## Claims

### Claim 1

A method of preparing a multi-use biomolecule lysate, comprising the steps of:
(a) heating a composition comprising a histopathologically processed biological sample and a reaction buffer at a temperature and a time sufficient to negatively affect protein cross-linking in said biological sample, and
(b) treating the resulting composition with an effective amount of a proteolytic enzyme for a time sufficient to disrupt the tissue and cellular structure of said biological sample.

### Claim at position 2

2-18. (canceled)

### Claim 19 (depends on 1)

A method of detecting one or more analytes in a multi-use biomolecule lysate suspected of containing said one or more analytes, comprising the steps of:
(a) contacting a multi-use biomolecule lysate according to claim 1 with an array, wherein said array comprises one or more capture agents of known binding specificity immobilized on a support surface in a positionally distinguishable manner; and
(b) detecting the binding or absence of binding of one or more analytes in said lysate to said immobilized capture reagents.

### Claim 20 (depends on 19)

The method according to claim 19, wherein at least one of said analytes is a protein.

### Claim 21 (depends on 20)

The method according to claim 20, wherein said capture reagent is selected from the group consisting of antibodies and antibody fragments, single domain antibodies, engineered scaffolds, peptides, nucleic acid aptamers, a receptor moiety, affinity reagents, small molecules, and protein ligands.

### Claim 22 (depends on 20)

The method according to claim 20, wherein the support surface comprises a material selected from the group consisting of glass, derivitized glass, silicon, derivitized silicon, porous silicon, plastic, nitrocellulose membranes, nylon membranes, and PVDF membranes.

### Claim 23

A method of analyzing a plurality of multi-use biomolecule lysates obtained from a plurality of histopathologically processed biological samples, comprising the steps of
(a) immobilizing a plurality of multi-use biomolecule lysates obtained from a histopathologically processed sample on a support surface, wherein each lysate is immobilized at a discrete location on said surface;
(b) contacting said support surface with a reagent of known binding affinity;
(c) detecting the presence or absence of binding of said reagent of known binding affinity at said discrete locations on said support surface.

### Claim 24 (depends on 23)

The method according to claim 23, wherein the multi-use biomolecule lysate is spotted onto the support surface by a method selected from the group consisting of manual spotting, ink-jetting, robotic contact printing, robotic non-contact printing and piezoelectric spotting.

### Claim 25 (depends on 23)

The method according to claim 23, wherein said reagent of known binding affinity is selected from the group consisting of antibodies and antibody fragments, single domain antibodies, engineered scaffolds, peptides, nucleic acid aptamers, a receptor moiety, affinity reagents, small molecules, and protein ligands.

### Claim 26 (depends on 23)

The method according to claim 23, wherein said support surface comprises a material selected from the group consisting of glass, derivitized glass, silicon, derivitized silicon, porous silicon, plastic, nitrocellulose membranes, nylon membranes, and PVDF membranes.

### Claim 27 (depends on 19)

The method according to claim 19 wherein at least one of said analytes is a nucleic acid.

### Claim 28 (depends on 27)

The method according to claim 27, wherein said multi-use biomolecule lysate is subjected to a fractionation step prior to contacting said lysate with said array.

### Claim 29 (depends on 27)

The method according to claim 27, wherein said nucleic acid comprises RNA.

### Claim 30 (depends on 27)

The method according to claim 27, wherein said nucleic acid comprises DNA.

### Claim 31 (depends on 23)

The method according claim 23, wherein the RNA-containing fraction of each lysate is immobilized on said support surface.

### Claim 32 (depends on 19)

The method according to claim 19, wherein the detecting step (b) is carried out using a detection reagent that specifically binds to one or more of the analytes suspected to be present in said sample.

### Claim 33 (depends on 32)

The method according to claim 32, wherein said detection reagents are proteins.

### Claim 34 (depends on 23)

The method according to claim 23, wherein one or more of said multi-use biomolecule lysates is subjected to a fractionation step prior to immobilizing one or more of the resulting fractions on said surface.

### Claim 35 (depends on 34)

The method according to claim 34, wherein the nucleic acid fraction of one or more lysates is immobilized on said surface.

### Claim 36 (depends on 35)

The method according to claim 35, wherein said nucleic acid fraction is an RNA-containing fraction.

### Claim 37 (depends on 35)

The method according to claim 35, wherein said nucleic acid fraction is a DNA-containing fraction.

### Claim 38 (depends on 34)

The method according to claim 34, wherein said fraction is a protein-containing fraction.

### Claim 39

(canceled)
